Stress axis dysfunction in schizophrenia

European Psychiatry

Volumn 20, Issue SUPPL. 3, 2005, Pages

  Yeap, S ^a   Thakore, J H ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Hypothalamic pituitary adrenal axis; Schizophrenia; Stress

Indexed keywords

APOMORPHINE; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DEXAMETHASONE; DEXFENFLURAMINE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; HALOPERIDOL; METOCLOPRAMIDE; NEUROLEPTIC AGENT; SEROTONIN; SULPIRIDE;

ANTICHOLINERGIC EFFECT; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; DRUG EFFECT; DRUG INHIBITION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROANATOMY; NEUROIMAGING; NEUROPHYSIOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STRESS;

EID: 31844451661     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(05)80181-6     Document Type: Article

References (82)

1. Abel K., O'Keane V., Murray R., and Cleare A. Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression Psychoneuroendocrinology 22 1997 539 548
2. Aleem A., Kulkarni A., and Yeragani V. Dexamethasone suppression test, schizophrenia and movement disorder Acta Psychiatr Scand 78 1998 689 694
3. Aleman A., Hijman R., and de Haan E. Memory impairment in schizophrenia: a meta-analysis Am J Psychiatry 156 1999 1358 1366
4. Armanini M., Hutchins C., and Stein B. Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent Brain Res 532 1990 7 12
5. Axelrod J., and Reisine T. Stress hormones: their interaction and regulation Science 224 1984 452 459
6. Axelson D., Doraiswamy P., and McDonald W. Hypercortisolaemia and hippocampal changes in depression Psychiatry Res 47 1993 163 173
7. Banki C., Bisette G., and Arato M. CSF corticotrophin-releasingfactor- like immunoreactivity in depression and schizophrenia Am J Psychiatry 144 1992 873 877
8. Beebington P., Bowen J., Hirsch S., and Kuipers E. Schizophrenia and psychosocial stresses S.R. Hirsch D.R. Weinberger Schizophrenia 1995 Blackwell Science 587 604
9. Brier A., and Buchanan R. The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients Life Sci 52 1992 1527 1534
10. Callicott J., Egan M., and Bertolino A. Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype Biol Psychiatry 44 1998 941 950
11. Chalmers D., Kwak S., Mansour A., Akil H., and Watson S. Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression J Neurosci 13 1993 914 923
12. Christie J., Whalley L., Dick H., Blackwood D., Blackburn I., and Fink G. Raised plasma cortisol concentration, a feature of drug-free psychotics and not speficis for depression Br J Psychiatry 148 1986 58 65
13. Condren R., and Thakore J. Cushing's disease and melancholia Stress 4 2001 91 119
14. Cotter D., and Pariante C. Stress and the progression of the developmental hypothesis of schizophrenia Br. J. Psychiatry 181 2002 363 365
15. Crossin K., Tai M., and Krushel L. Glucocorticoid receptor pathways are involved in the inhibition of astrocyte proliferation Proceedings of the National Academy of Sciences of the USA 94 1997 2687 2692
16. Davis K., Khan R., and Ko G. Dopamine in schizophrenia: a review and reconceptualization Am J Psychiatry 148 1991 1474 1486
17. Davies L., Arentzen R., and Reid J. Glucocorticoid sensitivity of vasopressin mRNA levels in the paraventricular nucleas of the rat Proc Natl Acad Sci USA 83 1996 1145 1149
18. Deicken R., Pegues M., and Amend D. Reduced hippocampal Nacetylaspartate without volume loss in schizophrenia Schizophre Res 82 1998 53 61
19. De Kloet E., Vreugdenhill E., Oitzl M., and Joels M. Brain corticosteroid receptor balance in health and disease Endocr Rev 19 1998 269 301
20. De Leon M., McRae T., and Tsai J. Abnormal cortisol response in Alzheimers disease linked to hippocampal atrophy [letter] Lancet 2 1988 391 392
21. Diamond D., Fleshner M., and Rose G. Psychological stress repeatedly blocks hippocampal primed burst potentiation in behaving rats Behav Brain Res 62 1994 1 9
22. Duval F., Mokrani M., Monreal J., Bailey P., Valdebenito M., Crocq M., and Macher J. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests Psychoneuroendocrinology 28 2003 627 642
23. Eberwine J., Jonassen J., and Evinger M. Complex transcriptional regulation by glucocorticoids and corticotrophin-releasing hormone of propiomelanocortin gene expression in rat pituitarycultures DNA Cell Biol 6 1987 483 492
24. Evans D., Burnett G., and Nemeroff C. The dexamethasone suppression test in the clinical setting American Journal of Psychiatry 140 1983 586 589
25. Fletcher P. The missing link: a failure of fronto-hippocampal integration in schizophrenia Nat Neurosci 1 1998 266 267
26. Fowles D. Schizophrenia: stress-diathesis revisited Annu Rev Psychol 43 1992 303 336
27. Gil-Ad I., Dickerman Z., Amdusky S., and Laron Z. Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenia as compared to control subjects Psychophramacology 88 1998 496 499
28. Green M. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153 1996 321 330
29. Heckers S., Raunch S., and Goff D. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia Nat Neurosci 1 1998 318 323
30. Hinson J. Panacrine control of adrenocortical function: a new role for the medulla? J Endocrinol 124 1990 7 9
31. Hoff A., Sakum M., Wieneke M., Horon R., Kushner M., and DeLIsi L. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia Am J Psychiatry 156 1999 1336 1341
32. Holmes M., French K., and Seckl J. Modulation of serotonin and corticosteroid receptor gene expression in the rat hippocampus with circadian rhythm and stress Mol Brain Res 28 1995 186 192
33. Holsboer-Trachsler E., Buol C., and Wiedemann K. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels Acta Psychiatrica Scandinavica 75 1997 608 613
34. Holsboer F. The endocrinology of mental disease. In: Grossman A.(Ed.), Clinical Endocrinology. Blackwell Science, Oxford, pp. 1096-1116
35. Ismail K., Murray R., and Wheeler M. The dexamethasone suppression test in schizophrenia Psychological Medicine 28 1998 3117
36. Jacobsen L., Giedd J., Costellanos F., Vaituzis A., Hamburger S., Kumra S., Lenane M., and Rapaport J. Progressive reduction in temporal lobe structures in childhood-onset schizophrenia Am J Psychiatry 155 1998 678 685
37. Jacobson L., and Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis Endocr Rev 12 1991 118 134
38. Jeste D., and Lohr J. Hippocampal pathologic findings in schizophrenia: a morphometric study Arch Gen Psychiatry 46 1989 1019 1024
39. Jonssan S., Luts A., and Guldberg-Kjaer N. Pyramidal neuron size in the hippocampus of schizophrenics correlates with total cell count and degree of cell disarray Eur Arch Psychiatry Clin Neurosci 249 1999 169 173
40. Kahn R., Davidson M., Siever L., Sevey S., and Davis K. Clozapine treatment and its effects on neuroendocrine responses induced by the serotonin agonist m-chlorophenylpiperazine Biol Psychiatry 26 2002 935 938
41. Kaneda Y., Fujii A., and Ohmori T. The hypothalamic-pituitary-adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics Prog Neuropsychopharmacol Biol Psychiatry 26 2002 935 938
42. Kaneko M., Toloyama F., and Hoshino Y. Hypothalamic-pituitaryadrenal axis function in chronic schizophrenia: association with clinical features Neuropsychobiology 25 1992 1 7
43. Kemali D., Maj M., Galderisi S., Ariano M., Cesarelli M., Milici N., Salvati A., Valente A., and Volpe M. Clinical and neuropsychological correlates of cerebral ventricular enlargement in schizophrenia J Psychiatr Res 19 1985 587 596
44. Keller-Wood M., and Dallman M. Corticoid inhibition of ACTH secretion Endrocr Rev 5 1984 1 24
45. Lammers C., Garcia Boreguero D., and Schmider J. Combined dexamethasone/corticotrophin releasing hormone test in patients with schizophrenia and in normal controls Biol Psychiatry 38 1995 803 807
46. Lawrie S., Whalley H., and Byrne M. Brain structure change and psychopathology in subjects at high risk of schizophrenia Schizophrenia Research 41 2000 11
47. Legros J., Gazzotti T., Carvelli T., Fanchimont P., Timsit-Barthier M., von Frenckell R., and Ansseau M. Apomorphine stimulation of vasopressin and oxytocin neurophysins: evidence for increased oxytocinergic and decreased vasopressinergic function inschizophrenics Psychoneuroendocrinology 17 1992 611 617
48. Linkowski P., Geenan V., Kerkhofs M., Mendlewicz J., and Legros J. Cerebrospinal fluid neurophysins in affective illness and in schizophrenia Eur Arch Psychiatry Neurol Sci 234 1984 162 165
49. Lundblad J., and Roberts J. Regulation of propiomelanocortin gene expression in pituitary Endocr Rev 9 1998 135 158
50. Malaspina D., Perera G., and Lignelli A. SPECT imaging of odor identification in schizophrenia Psychiatry Res 82 1998 53 61
51. Mauri M., Sinforiani E., and Bono G. Memory impairment in Cuchings Disease Acta Neurol Scand 87 1993 52 55
52. McEwen B., Brinton R., and Sapolsky R. Glucocorticoid receptors and behaviour: implications for the stress response Adv Exp Med Biol 245 1988 35 45
53. McEwen B., De Kloet E., and Roatene W. Adrenal steroid receptors and actions in the nervous system Physiol Rev 66 1986 1121 1188
54. McEwen B., and Stellar E. Stress and the individual. Mechanisms leading to disease Arch Int Med 153 1993 2093 2101
55. McEwen B. Stress and the hippocampus: an update on current knowledge Presse Med 20 1991 1801 1806
56. Meltzer H. The importance of serotonin-dopamine interactions in the action of clozapine Br J Psychiatry 160 1992 22 29
57. Newcomer J., Faustman W., and Whiteford H. Symptomatology and cognitive impairment associate independently with postdexamethasone cortisol concentrations in unmedicated schizophrenicpatients Biol Psychiatry 29 1991 855 864
58. Norman R., and Malla A. Stressful life events and schizophrenia: a review of the research Br J Psychiatry 62 1993 161 166
59. Pariante C., and Miller A. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment Biol Psychiatry 49 2001 391 404
60. Pariante C.M., Vassilopoulou K., Velakoulis D., Phillips L., Soulsby B., Wood S.J., Brewer W., Smith D.J., Dazzan P., Yung A.R., Zervas I.M., Christodoulou G.N., Murray R., McGorry P.D., and Pantelis C. Pituitary volume in psychosis Br J Psychiatry 185 2004 5 10
61. Pantellis C., Velakoulis D., and Suckling J. Left medial temporal lobe volume reduction occurs during the transition from high risk to first episode psychosis Schizophrenia Research 41 2000 35
62. Purdon S., Jones B., and Stip E. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzepine, risperidone, or haloperidol. Arch Gen Psychiatry 57 2000 249 258
63. Rao L., and Kolsch H. Effects of estrogen on brain development and neuroprotection - implications for negative symptoms in schizophrenia Psychoneuroendocrinology 28 2003 83 96
64. Risch S., Lewine R., Kaline N., Jewart R., Risby E., Caudle J., Stipetic M., Turner J., Eccard M., and Pollard W. Limbic-hypothamalmic-pituitaryadrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia Neuropsychopharmacology 6 1992 95 100
65. Roy A., Pickar D., and Doran A. The corticotrophin releasing hormone stimulation test in chronic schizophrenia Am J Psychiatry 143 1986 1393 1397
66. Ryan M., Sharifi N., Condren R., and Thakore J. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia Psychoneuroendocrinology 29 2004 1065 1070
67. Sapolsky R., Krey L., and McEwen B. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis Endrocr Rev 7 1986 284 301
68. Sapolsky R. Stress, glucocorticoids, and the damage to the nervous system: the current state of confusion Stress 1 1996 1 11
69. Sapolsky R. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death Biological Psychiatry 48 2000 755 765
70. Sapolsky R., Meaney M., and McEwen B. The development of the glucocorticoid receptor system in the rat limbic brain. III. Negative-feedback regulation Brain Res 350 1985 169 173
71. Sharma R., Pandey G., and Janicak P. The effect of diagnosis and age on the DST: a metaanalytic approach Biological Psychiatry 24 1998 555 568
72. Sucheki D., Nelson D., and Van Oers H. Activation and inhibition of the hypothalamic-pituitary-adrenal axis of the neonatal rat: effects of maternal deprivation Pschoneuroendocrinology 20 1995 169 182
73. Tandon R., Mazzara C., and DeQuardo J. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome Biological Psychiatry 29 1991 953 964
74. Todtenkopf M., and Benes F. Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain Synapse 29 1998 323 332
75. Van Canter E., Linkowski P., Kerhofs M., Hubain P., L'Hermite-Baleriaux M., and Leclerq R. Circadian and sleep related endocrine rhythms in schizophrenia Arch Gen Psychiatry 48 1991 348 356
76. Walker E., and Diforio D. Schizophrenia: a neural diathesis-stress model Psychol Rec 104 1997 667 685
77. Walsh P., Spelman L., Shariff N., and Thakore J.H. Male patients with paranoid schizophrenia have greater ACTh and cortisol secretion in response to metoclopramide-induced AVP release Psychoneuroendocrinology 30 2005 431 437
78. Webster M., O'Grady J., and Orthmann C. Decreased glucocorticoid receptor mRNA levels in individuals with depression, bipolar disorder and schizophrenia Schizophrenia Research 41 2000 111
79. Weinberger D. Cell biology of the hippocampul formation in schizophrenia Biol Psychiatry 45 1999 395 402
80. Wik G. Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood J Endocrinol 144 1995 425 429
81. Wright I., Rabe-Hasketh S., and Woodruff P. Meta-analysis of regional brain volumes in schizophrenia Am J Psychiatry 157 2000 16 25
82. Yehuda R., Southwick S., and Nussbaum G. Low urinary cortisol excretion in patients with posttraumatic stress disorder J Nerv Ment Dis 178 1990 366 369